RLAY
Relay Therapeutics, Inc. · Healthcare
President and CEO Sanjiv Patel sold $2.6M of Relay Therapeutics, Inc.
Sold$2,639,280
$31.42Price
84,000Shares
−25%Stake
What RLAY did after the filing
- The stock from Mon, Apr 18 open, $30.74
- −47.0%
- S&P 500, same days
- −5.5%
Measured over 30 trading days, to the May 31 close.
Traded Tue, Apr 12. Filed Thu, Apr 14, 5:20 PM ET, after the close. Returns use the Apr 18 open and the May 31 close. Not investment advice.